Delhi HC Issues Notice on Contempt Plea filed by ANI Media Private Limited  ||  Rights of Mutation: Del. HC Initiates Suo Motu PIL Over Lack of Policies for Mutation of Property  ||  All. HC: Can’t Implicate Co-Accused u/s 149 when there is No Meeting of Mind Regarding Common Object  ||  SC: Factum of Causing Injury Not Relevant When Accused Roped in as Member of Unlawful Assembly  ||  Meghalaya Govt. to SC: Circular Issued Regarding Prohibition of 'Two Finger test' on Rape Survivors  ||  SC: No Minimum Sentence Prescribed for Conviction Under Section 304(A) and 338 of IPC  ||  Kar. HC: Offence Under Widlife Protection Act Shouldn’t be Kept Pending for Very Long  ||  Mad. HC: Courts Have Power to Grant Maintenance to Muslim Woman Who Has Filed for Divorce  ||  Bom. HC: Bail Granted to Man on Ground of Having No Intention to Disrupt Public Peace  ||  MP HC: Transferring Accused Merely Because ICC Proceedings are Pending is Unjustified    

Search Results for Tag : diabetes

Notifications & Circulars

Dr. Jitendra Singh releases 'Indian Guidelines for Diabetes Management'(09.05.2018)

The Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances.....

Tags : Guidelines, Diabetes Management, Release



Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



News

Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin”(14.12.2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporatio.....

Tags : Kolkata Patent Office, Patent , Diabetes Drug Teneligliptin



Delhi HC Sets Aside Centre's Ban on FDCs for Type-2 Diabetes(18.02.2019)

Delhi High Court has set aside Centre's notifications banning manufacture and sale of fixed drug combinations (FDCs) used for treatment of Type-2 diab.....

Tags : Delhi High Court, FDCs for Type-2 Diabetes



Disclaimer | Copyright 2024 - All Rights Reserved